Histidine supplement to boost immunity in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether taking a histidine supplement (an amino acid building block) alongside standard colorectal cancer treatment helps your immune system fight the cancer better. Researchers want to see if this simple addition can improve outcomes for people with stage II or higher colorectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–80 years old
- Your body mass index (BMI) is 18.5 or higher
- You have stage II or higher colorectal cancer and need medical treatment
- You can swallow and take oral medication by mouth
- You are not currently in another study testing drugs, supplements, or devices
- You have no severe digestive problems like bleeding, vomiting, or blockages that would prevent you from taking this supplement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether intravenous vitamin C (ascorbic acid) combined with an immune treatment (adebrelimab) can slow or shrink metastatic colorectal cancer that can’t be removed with surgery. It focuses on tumors that strongly show a specific marker called GLUT3, and aims to see if the combination works better than standard approaches.
This study explores whether a nutrient called histidine affects how well immunotherapy (a type of cancer-fighting treatment) works in colorectal cancer patients. Researchers will examine blood and tissue samples to understand this connection and potentially improve treatment outcomes.
This study tests how much protein people with colorectal or breast cancer need during treatment or recovery. It may help improve nutrition guidance and support for maintaining health during chemo or after surgery.
This study looks at how diet and gut bacteria affect colon cancer risk in Black and Non-Hispanic White adults aged 45 to 75 who are at higher risk. You would donate mouth and stool samples and complete food recalls.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This trial tests a treatment made from your own immune cells (called TILs) that are taken from your tumor, grown in a lab, and given back to you along with immunotherapy. It is for people with advanced colon or rectum cancer who have run out of standard options.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.